Armand Butera

The authors of a recent review recommend continued research on “powerful” new treatment methods that are effective in treating atopic diseases such as atopic eczema.

Investigators believe their study shows the efficacy and safety of the 2 biologic agents, which are known to have anti-inflammatory and immunosuppressant qualities.

Investigators have found a negative association between the COPD and proton pump inhibitors through a familiar sequence symmetry analysis approach used to find associations between COPD and gastro-esophageal reflux disease.

Though operating room-based injections are predominantly performed, investigators could not find sufficient data that confirmed it as the only safe injection site.

The new growth hormone has a weekly injection rate, as opposed to the daily injection rates of other growth hormones such as somatropin.

The investigative team in Canada found that pre-pregnancy weight may possibly influence a child’s risk of developing pediatric allergic diseases.

Investigators believe the treatment strategy can go on to treat other “difficult-to-treat” areas of the body such as palms, elbows, and lips.

A new study shows that research and educational resources are greatly lacking regarding skin color and dermatology education.

Investigators found that patients who were not treated with biologic medications were at a significantly increased risk of developing psoriatic arthritis.

Though investigators called for more research on the biologic, recent data showed patients treated with bimekizumab recorded improved skin pain when compared to placebo and adalimumab.

Investigators found that intralymphatic immunotherapy of was not superior to placebo or other forms of allergen-specific immunotherapy, but felt continued research was warranted.

Investigators gathered data from vulnerable populations with rheumatic disease regarding their thoughts and opinions on the COVID-19 virus.

Investigators found that despite a lack of infrastructure on pediatric quality improvement, higher-performing hospitals can sustain cost-effective strategies for pediatric asthma care.

Investigators write that methods such as dermatoscopy can result in early recognition of unstable patches and lead to appropriate medical treatment for patients with vitiligo.

The good care practices cited in the study can lead to increased care of patients with atopic dermatitis and are able to be implemented in any practice.

Developed by BrainsWay, the new device has been shown to decrease anxiety symptoms in adult patients with anxious depression.

Investigators found that children with antibiotic allergy labels have longer hospital stays and increased symptoms of allergic reaction.

The stigma surrounding gout has contributed to the general unease patients have about their condition.

Research suggests that men and women of all ages in mainland China recorded similar results of untreated osteoporosis and vertebral and clinical fractures, all of which are becoming more prevalent over time.

Dr. LaMoreaux believes that to treat gout in patients with proper medications and therapies, doctors must first establish trust and combat the stigma surrounding this painful form of arthritis.

Though no research on the effects of positive emotion intervention on children with asthma exist, investigators note that the methods have shown positive results in other health contexts.

Recent data from phase 3 clinical trials of the antibody shows significant skin clearance and itch in people with atopic dermatitis.

With immunosuppressed populations at an increased risk of death and comorbidities due to COVID-19, members of the Advisory Committee of Immunization Practices moved to approve additional doses for young at-risk patients.

Investigators link early atopic manifestations and other complications to tree nut allergy, which account for most of all food related deaths by anaphylaxis.

Staff from schools across the United Kingdom express desire for enhanced staff preparedness and internal allergy policy review after being surveyed by investigators.

Investigators from Spain contribute to the dialogue surrounding postvaccine antibodies with a study that looks exclusively at the COVID-19 vaccine’s affect on breastfeeding mothers.

Dr. Blauvelt speaks on the results of the phase 3b Heads Up study, and the future of upadacitinib and dupilumab in atopic dermatitis management.

An ongoing study of the IL-17A and IL-17F inhibitor showed patients with moderate to severe plaque psoriasis achieved long-term skin clearance results.

A new follow-up study highlights the efficacy and safety of the daily oral immunotherapy in. younger patient populations.